PDCD1 and osteosarcoma: In a study of osteosarcoma, anti-PD-1 treatment increased overall survival and decreased intra-tumoral Ki67+Foxp3+CD4+ Treg cells in osteosarcoma-bearing mice, compared with sham-treated control (59).